FDA Inspection 1121294 — Hetero Drugs Limited

Hetero Drugs Limited — FEI 3003510514

The FDA completed an inspection of Hetero Drugs Limited on Feb 14, 2020 in Gummadidala Mandal, Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gummadidala Mandal, Sangareddy (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.